eIF4AIII Antibody (B-2): sc-365549. Western blot analysis of eIF4AIII expression in MCF7 (A) and HeLa (B) nuclear extracts and NIH/3T3 whole cell lysate (C). Detection reagent used: m-IgGκ BP-HRP: sc-516102.
Not CRISPR data: the image illustrates antibody quality for visualizing CRISPR experiment results.
eIF4AIII Antibody (B-2): sc-365549. Western blot analysis of eIF4AIII expression in MCF7 (A) and HeLa (B) nuclear extracts and NIH/3T3 whole cell lysate (C). Detection reagent used: m-IgGκ BP-HRP: sc-516102.
Not CRISPR data: the image illustrates antibody quality for visualizing CRISPR experiment results.
20 µg of transfection-ready, purified plasmid DNA; Suitable for up to 20 transfections
eIF4AIII Double Nickase Plasmid (m) consists of a pair of plasmids each encoding a D10A mutated Cas9 nuclease and a target-specific 20 nt guide RNA (gRNA) designed to knockout gene expression with greater specificity than its CRISPR/Cas9 KO counterpart
Paired gRNA sequences are offset by approximately 20 bp to allow for specific Cas9-mediated double nicking of the genomic DNA, which mimics a DSB
One plasmid in the pair contains a puromycin-resistance gene for selection; the other plasmid in the pair contains a GFP marker to visually confirm transfection
eIF4AIII Double Nickase Plasmid (m) and eIF4AIII Double Nickase Plasmid (m2) encode distinct paired gRNA designs targeting Eif4a3. One or both designs may be available
Following transfection, gene knockout efficiency can be assayed by WB, IF or IHC using antibody: eIF4AIII Antibody (B-2): sc-365549